MyFinsight
Home
Blog
About
Product
$898,616K
(31.11%↑ Y/Y)
Other Revenue
$15,589K
Product
$499,714K
(16.54%↑ Y/Y)
Other Revenue
$6,307K
Product
$208,403K
(36.82%↑ Y/Y)
Other Revenue
$352K
Product
$73,061K
(105.43%↑ Y/Y)
Other Revenue
$3,029K
US
$914,205K
(31.65%↑ Y/Y)
CN
$506,021K
(16.88%↑ Y/Y)
Europe
$208,755K
(36.99%↑ Y/Y)
All Other Countries
Except China And United...
$76,090K
(113.95%↑ Y/Y)
Total revenues
$1,705,071K
(29.63%↑ Y/Y)
Gross profit
$1,530,541K
(33.01%↑ Y/Y)
Cost of sales -
product
$174,530K
(6.03%↑ Y/Y)
Income from operations
$325,047K
(269.85%↑ Y/Y)
Interest income
$27,900K
Total operating
expenses
$1,205,494K
(13.43%↑ Y/Y)
Income before income
taxes
$312,459K
(213.87%↑ Y/Y)
Interest expense
$39,739K
Other (expense)
income, net
-$749K
(-109.17%↓ Y/Y)
Research and development
$612,280K
(16.65%↑ Y/Y)
Selling, general and
administrative
$593,214K
(10.28%↑ Y/Y)
Net income
$237,007K
(151.28%↑ Y/Y)
Income tax expense
$75,452K
(1342.95%↑ Y/Y)
Back
Back
Income Statement
BeOne Medicines Ltd. (BEIGF)
BeOne Medicines Ltd. (BEIGF)
source: myfinsight.com